key: cord-0748466-k6buif5h
authors: Oehler, Daniel; Bruno, Raphael Romano; Boeken, Udo; Westenfeld, Ralf
title: Moderate acceptance of COVID‐19 vaccination in patients pre‐ and post‐heart transplantation: Experiences from a German Transplant Centre
date: 2021-07-12
journal: Transpl Infect Dis
DOI: 10.1111/tid.13681
sha: 4d24c39355066b403df2135ad177252801cc6e5d
doc_id: 748466
cord_uid: k6buif5h

INTRODUCTION AND OBJECTIVES: Patients awaiting heart transplantation (HTx) are at increased risk developing severe coronavirus disease 2019 (COVID‐19). Patients supported by a left ventricular assist device (LVAD) face additional risks due to coagulopathies during COVID‐19. Following HTx, elevated risk factors for severe COVID‐19 persist due to chronic immunosuppression and frequent comorbidities. Taken together, COVID‐19 vaccination is of critical importance in all three patient cohorts. Here, we report our experience to deliver COVID‐19 vaccination in a German transplant center. METHODS AND RESULTS: We screened 211 patients for contraindications and offered the remaining 186 eligible patients COVID‐19 vaccination. Of those, 133 patients (71%) accepted the offer and were vaccinated. Acceptance of vaccination differed between HTx recipients (84 of 113, 74%), patients on the waiting list (34 of 47, 72%), and patients with LVAD support (28 of 50, 56%). The LVAD cohort demonstrated lower acceptance levels for vaccination compared to HTx recipients and patients awaiting HTx (74% vs. 56%; p = 0.028). CONCLUSION: We demonstrate for the first time only moderate acceptance levels of COVID‐19 vaccination in HTx recipients and candidates on the waiting list compared to general population, despite perceived high‐risk for severe disease. Additionally, those supported by LVAD have even lower adherence. Efforts may need to be made to increase acceptance in this vulnerable as well as cost‐intensive patient cohort.

Cardiovascular comorbidities are a major risk factor for adverse outcome of coronavirus disease 2019 (COVID-19). 1 Thus, patients awaiting heart transplantation (HTx) are perceived at increased risk.

Following HTx, elevated risk factors for severe COVID-19 persist due to chronic immunosuppression and frequent comorbidities. [2] [3] [4] [5] Patients supported by a left ventricular assist device (LVAD) face additional risks due to coagulopathies during COVID-19. Taken together, delivery of COVID-19 vaccination is critically important in all three patient cohorts. Here, we report our experience to provide COVID vaccination to these patients in a German transplant center and investigate whether acceptance of vaccination differs between these groups. 

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

COVID-19 in solid organ transplant recipients: a single-center case series from Spain

COVID-19 in solid organ transplant: a multi-center cohort study

COVID-19 in kidney transplant recipients

COVID-19 in solid organ transplant recipients: initial report from the US epicenter

A global survey of potential acceptance of a COVID-19 vaccine

Acceptance of a COVID-19 vaccine and its related determinants among the general adult population in Kuwait

KFF Covid-19 Vaccine Monitor

Moderate acceptance of COVID-19 vaccination in patients pre-and post-heart transplantation: Experiences from a German Transplant Centre

Daniel Oehler wrote the main manuscript text and prepared the figure.All authors reviewed the manuscript.

Daniel Oehler https://orcid.org/0000-0002-0435-4119Raphael Romano Bruno https://orcid.org/0000-0003-3776-3530Udo Boeken https://orcid.org/0000-0001-8128-9659Ralf Westenfeld https://orcid.org/0000-0001-7058-3051